India prohibits all exports of hydroxychloroquine. It is a malaria medicine that President Donald Trump has presented as a “game-changer” in the fight with COVID 19.
The Directorate General of Foreign Trade of India said on April 4;
The export and manufacture of drugs prohibited “with no immunity” and with quick results. The trade regulator last month banned the overseas delivery of drugs. It has the permission of just restricted immunity like on a humanitarian basis and for earlier meeting promises.
Speaking at a press meeting on Saturday, Trump stated;
He contacted Indian Prime Minister Narendra Modi. He also requested the let go of US shipments that already have permission. Further, he said that India is paying serious attention to his appeal.
There is no definitive systematic indication that hydroxyurea can cure a new pathogen contagion.
India is not much faster as compared to other countries in testing the new Coronavirus.
The ban on hydroxychloroquine export shows India’s growing worry over the fast feast of the Coronavirus, with 1.3 billion people endangering public outbursts in the country. India has recorded 3,374 positive cases so far and has lost 77 lives, according to the federal health ministry.
The Federal Health Ministry stated;
Three thousand three hundred seventy-four positive confirmed cased have been recorded in India, and 77 died.
The country fight to stay people at home in the three-week shutdown as began March 25, prompting a sharp rise in outbursts.
Read Coronavirus hits U.S. payrolls, another Great Recession coming
This website uses cookies.